Barinthus Biotherapeutics • BRNS
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
$57.1M
Market Cap • 25/07/20242016
(há 8 anos)
2021
(3 years ago)
NASDAQ
Listagem
Harwell
Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
BRNSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.